我国药物经济学评价研究的现状、问题及建议

目的:了解我国药物经济学评价研究的现状和存在的问题,并为将来的发展提出建议。方法:从研究者单位、研究方法、研究角度、研究对象、研究时限、临床试验、成本、产出、成本产出分析、敏感度分析、不良反应测量、研究结论方面进行文献分析。结果:我国药物经济学评价研究在各方面均存在着不同程度的问题。结论:我国药物经济学评价研究尚处起步阶段,今后需要不断发展完善。

Pharmacoeconomic Evaluation Studies in China: Status Quo, Problems and Suggestions

OBJECTIVE： To analyze the current status and existing problems of pharmacoeconomic evaluation studies in China, and to put forward suggestions for its future development. METHODS： The pertinent literature was analyzed from aspects of author affiliation, research method, research perspective, research object, research duration, clinical trial, cost, outcome, cost- output analysis, sensitivity analysis, ADR（adverse drug reaction） measurement, and research conclusion. RESULTS： There were still many problems in Chinese pharmacoeconomic evaluation studies. CONCLUSION： Chinese pharmacoeconomic evaluation studies are still in an infant stage, which remain to be further improved.